Spaze Ventures

Spaze Ventures is a Singapore-based early-stage venture firm with a generalist Asia-Pacific mandate, investing across software, consumer, enterprise, and emerging technology themes. Public detail on healthcare specificity, AI focus, and exact check size is limited from the inputs provided, but firms of this profile typically deploy seed and pre-Series A checks in the range of two hundred fifty thousand to one million Singapore dollars, with the ability to follow on selectively. Healthcare AI founders can engage if the company has meaningful Southeast Asia exposure or ambitions, where the firm’s regional network provides distribution, partnership, and follow-on capital connections. The natural fit is a software-led healthcare company solving problems in markets where Singapore, Indonesia, Malaysia, Vietnam, the Philippines, or India represent material end-markets. Companies purely focused on the United States or Europe, or those building regulated therapeutics and complex devices that require specialized healthcare expertise, are unlikely to fit. Founders should not expect deep clinical or regulatory coaching from a generalist regional firm, but should value the network access into the Southeast Asian ecosystem of operators, regulators, and corporate partners. The best entry path is a warm introduction from a portfolio CEO, a regional banker, or a Southeast Asian operator. Direct outreach to the firm via LinkedIn or the website is acceptable, ideally paired with a sharp summary of the regional opportunity, traction signals, and a clear use-of-proceeds tied to the next twelve to eighteen months.